Smart inhalers that track medication usage, dose timing, and technique with wireless data transmission.
User-friendly mobile application for patients to view data, receive reminders, and access educational content.
Web-based platform for healthcare providers to monitor patient data, generate reports, and manage care plans.
Enables continuous tracking of respiratory metrics from home, reducing need for in-person visits.
HIPAA-compliant data storage and encryption to ensure patient privacy and regulatory adherence.
Advanced analytics tools for trend analysis, population health insights, and outcome measurement.
Helps patients with asthma track medication adherence and lung function to prevent exacerbations and improve control.
Supports chronic obstructive pulmonary disease patients in managing symptoms and reducing hospital readmissions through remote monitoring.
Assists children and caregivers in managing asthma with engaging tools and simplified data sharing with pediatricians.
Provides digital endpoints and real-time data collection for respiratory-focused clinical trials to enhance accuracy and efficiency.
Enables virtual consultations by sharing patient data with healthcare providers for informed remote decision-making.
Facilitates smooth transitions from hospital to home by ensuring medication adherence and monitoring post-discharge.
Allows healthcare organizations to analyze aggregate data for identifying trends and improving respiratory care programs.
Helps pharmacies and insurers implement adherence initiatives to reduce costs and improve patient outcomes.
Uses data visualizations and feedback to educate patients on proper inhaler techniques and self-management.
Monitors high-risk patients during environmental triggers or pandemics to enable timely interventions.
Sign in to leave a review
Activ Surgical is an innovative medical technology company that develops intelligent surgical systems designed to enhance precision and outcomes in various surgical procedures. Their platform leverages artificial intelligence (AI), augmented reality (AR), and computer vision to provide real-time visualization and data-driven guidance during surgeries. Aimed at improving patient safety and reducing complications, the technology integrates seamlessly with existing surgical equipment, such as endoscopes and imaging systems, to overlay critical anatomical information and optimize surgical paths. This assists surgeons in making informed decisions, particularly in minimally invasive and complex open surgeries. By digitizing surgical processes, Activ Surgical contributes to the advancement of surgical care through enhanced efficiency, accuracy, and training capabilities. The system is adaptable across multiple surgical specialties, supporting a future where AI-driven tools become standard in operating rooms for better healthcare delivery.
BenevolentAI is a technology company that leverages artificial intelligence to accelerate and enhance drug discovery and development processes. By integrating vast biomedical datasets with advanced machine learning algorithms, the platform enables researchers to identify novel drug targets, predict drug efficacy and safety, optimize clinical trial designs, and repurpose existing drugs for new indications. Focused on addressing diseases with high unmet medical needs, such as cancer and neurological disorders, BenevolentAI aims to transform the pharmaceutical industry by reducing the time, cost, and failure rates associated with bringing new therapies to market. The platform combines AI-driven insights with domain expertise, providing a collaborative environment for scientists to generate hypotheses, validate candidates, and streamline decision-making in research pipelines. Its comprehensive approach includes data analysis, predictive modeling, and integration with existing laboratory systems, making it a powerful tool for biotech and pharma companies seeking innovation in drug development.
Biofourmis is a pioneering digital health company that specializes in AI-driven remote patient monitoring and personalized care solutions. Their flagship platform, Biovitals, leverages advanced machine learning algorithms to analyze continuous physiological data collected from wearable sensors. This enables healthcare providers to monitor patients in real-time, detect early signs of health deteriorations, and intervene proactively. The platform is designed to manage a wide range of clinical conditions, including chronic heart failure, diabetes, hypertension, and post-operative recovery. By integrating seamlessly with electronic medical record systems, Biofourmis facilitates efficient data flow and enhances clinical decision-making. The company serves various stakeholders, from large hospital systems to pharmaceutical companies conducting decentralized clinical trials. Biofourmis aims to improve patient outcomes, reduce hospital readmissions, and lower healthcare costs through data-driven insights. Their technology is scalable, secure, and compliant with global healthcare regulations, making it a trusted partner in transforming care delivery. With a focus on innovation, Biofourmis continues to expand its capabilities, offering tools for predictive analytics, personalized treatment plans, and population health management.
